Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M DaCosta

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 13, 2022
Mice Lacking <i>Gpr75</i> are Hypophagic and ThinDavid R Powell, Deon D Doree, Christopher M DaCosta, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 18, 2020
Obesity of <i>G2e3</i> Knockout Mice Suggests That Obesity-Associated Variants Near Human <i>G2E3</i> Decrease G2E3 ActivityDavid R Powell, Deon D Doree, Christopher M DaCosta, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Effect of LX4211 on glucose homeostasis and body composition in preclinical modelsDavid R Powell, Christopher M DaCosta, Melinda Smith, et al.
Molecular and Cellular Biology|October 27, 2010
Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and functionDavid P Harris, Peter Vogel, Marie Wims, et al.
Journal of Medicinal Chemistry|September 30, 2009
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesNicole C Goodwin, Ross Mabon, Bryce A Harrison, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 6, 2021
High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat PhenotypesDavid R Powell, Jean-Pierre Revelli, Deon D Doree, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 15, 2012
Improved glycemic control in mice lacking Sglt1 and Sglt2David R Powell, Christopher M DaCosta, Jason Gay, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2017
LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in MiceDavid R Powell, Melinda G Smith, Deon D Doree, et al.
Obesity (Silver Spring, Md.)|August 23, 2008
High-throughput screening of mouse knockout lines identifies true lean and obese phenotypesRobert Brommage, Urvi Desai, Jean-Pierre Revelli, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|January 13, 2022
Mice Lacking <i>Gpr75</i> are Hypophagic and ThinDavid R Powell, Deon D Doree, Christopher M DaCosta, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 18, 2020
Obesity of <i>G2e3</i> Knockout Mice Suggests That Obesity-Associated Variants Near Human <i>G2E3</i> Decrease G2E3 ActivityDavid R Powell, Deon D Doree, Christopher M DaCosta, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2014
Effect of LX4211 on glucose homeostasis and body composition in preclinical modelsDavid R Powell, Christopher M DaCosta, Melinda Smith, et al.
Molecular and Cellular Biology|October 27, 2010
Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and functionDavid P Harris, Peter Vogel, Marie Wims, et al.
Journal of Medicinal Chemistry|September 30, 2009
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetesNicole C Goodwin, Ross Mabon, Bryce A Harrison, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 6, 2021
High-Throughput Screening of Mouse Gene Knockouts Identifies Established and Novel High Body Fat PhenotypesDavid R Powell, Jean-Pierre Revelli, Deon D Doree, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 15, 2012
Improved glycemic control in mice lacking Sglt1 and Sglt2David R Powell, Christopher M DaCosta, Jason Gay, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 27, 2017
LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in MiceDavid R Powell, Melinda G Smith, Deon D Doree, et al.
Obesity (Silver Spring, Md.)|August 23, 2008
High-throughput screening of mouse knockout lines identifies true lean and obese phenotypesRobert Brommage, Urvi Desai, Jean-Pierre Revelli, et al.
Pageof 1